Model
Edge
Alnylam Pharmaceuticals, Inc.
0001298814
Filing Type
4
Filing Date
2/26/2023
Updated
2/27/23, 9:11 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership